Pioglitazone Hydrochloride Tablets USP 15 mg — Class II drug recall D-0140-2020
Terminated recall by Macleods Pharma Usa Inc, reported 2019-10-23. Superpotent
| Recall number | D-0140-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Macleods Pharma Usa Inc, Plainsboro, NJ, United States |
| Recall initiated | 2019-09-23 |
| Classified | 2019-10-11 |
| Reported by FDA | 2019-10-23 |
| Terminated | 2021-02-23 |
| Quantity | 31,968 bottles |
| Reason classes | potency |
| NDC | 33342-0054, 33342-0054-07, 33342-0054-10, 33342-0054-12, 33342-0054-15, 33342-0055, 33342-0055-07, 33342-0055-10, 33342-0055-12, 33342-0055-15, 33342-0056, 33342-0056-07, 33342-0056-10, 33342-0056-12, 33342-0056-15 |
| Lot numbers | BPF901A |
| Expiration dates | 2021-12 |
Product
Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07
Reason for recall
Superpotent
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0140-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.